Core Insights - Cognizant Technology Solutions (CTSH) reported non-GAAP earnings of 1.23pershareforQ12025,exceedingtheZacksConsensusEstimateby3.365.12 billion, surpassing the consensus mark by 0.95%, with a year-over-year growth of 7.5% and 8.2% at constant currency [1] - The Belcan acquisition contributed approximately 400 basis points to revenue growth, while bookings increased 3% year over year to 26.7billion,indicatingabook−to−billratioofabout1.3times[2]FinancialPerformance−Financialservicesrevenues,accountingfor28.61.462 billion, driven by increased discretionary spending and investments in cloud and AI [4] - Health Sciences revenues, making up 30.7% of total revenues, rose 10.9% year over year to 1.571billion,supportedbystrongdemandacrossvarioussectors[5]−ProductsandResourcesrevenuesincreased12.81.27 billion, while Communications, Media and Technology revenues decreased 2.7% to 804million[5]RegionalPerformance−NorthAmericacontributed75.31.99 billion, down from 2.24billionattheendof2024[9]−Totaldebtdecreasedto600 million from 908million,whilecashgeneratedfromoperationswas400 million compared to 920millioninthepreviousquarter[9]FutureGuidance−ForQ22025,revenuesareexpectedtobebetween5.14 billion and 5.21billion,indicatinggrowthof5.920.5-21billion,reflectinganincreaseof3.9−6.44.98 and $5.14 [11]